The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Tsvetkova A.V.

Group of companies «MEDSI»;
Sechenov First Moscow State Medical University

Koneva E.S.

Center of Restorative Medicine of the MEDSI group;
Sechenov First Moscow State Medical University

Kostenko A.A.

City Clinical Hospital No. 52

Bisheva D.R.

Sechenov First Moscow State Medical University

Sidyakina I.V.

Group of companies «MEDSI»

Konev S.M.

Sechenov First Moscow State Medical University;
Group of companies «MEDSI»

Zhumanova E.N.

Center of gynecology, oncology, reproductive and aesthetic medicine in Clinical hospital No. 1 of JSC GC «Medsi», Krasnogorsk, Otradnoe;
Central state medical Academy of the presidential administration of the Russian Federation

Illarionov V.E.

Central state medical Academy of the presidential administration of the Russian Federation

Shestakov A.V.

FGBNU "Russian Scientific Center for Surgery named after acad. B.V. Petrovsky Russian Research Center for Surgery

The role of systemic ozone therapy in the rehabilitation of patients after COVID-19

Authors:

Tsvetkova A.V., Koneva E.S., Kostenko A.A., Bisheva D.R., Sidyakina I.V., Konev S.M., Zhumanova E.N., Illarionov V.E., Shestakov A.V.

More about the authors

Read: 3404 times


To cite this article:

Tsvetkova AV, Koneva ES, Kostenko AA, et al. . The role of systemic ozone therapy in the rehabilitation of patients after COVID-19. Problems of Balneology, Physiotherapy and Exercise Therapy. 2022;99(4‑2):22‑29. (In Russ.)
https://doi.org/10.17116/kurort20229904222

Recommended articles:
Effi­ciency of complex medi­cal reha­bilitation after pulmonary enda­rterectomy. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(6):629-636
The role of drug Cyto­flavin in the correction of dysautonomia in patients with post-COVID syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):140-146

References:

  1. Garg P, Arora U, Kumar A, Wig N. The «post-COVID» syndrome: How deep is the damage? J Med Virol. 2021;2(93):673-674.  https://doi.org/10.1002/jmv.26465
  2. Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens D, Hastie C, O’Hara M, Suett JC, Burls A, Foote C, Carson G, Olliaro P, Sigfrid L, Stavropoulou C. Characterising longterm COVID-19: a rapid living systematic review. medRxiv. 2021. https://doi.org/10.1101/2020.12.08.20246025
  3. Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, Walshaw C, Kemp S, Corrado J, Singh R, Collins T, O’Connor RJ, Sivan M. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2021;93(2):1013-1022. https://doi.org/10.1002/jmv.26368
  4. Raman B, Cassar MP, Tunnicliffe EM, Filippini N, Griffanti L, Alfaro-Almagro F, Okell T, Sheerin F, Xie C, Mahmod M, Mózes FE, Lewandowski AJ, Ohuma EO, Holdsworth D, Lamlum H, Woodman MJ, Krasopoulos C, Mills R, McConnell FAK, Wang C, Arthofer C, Lange FJ, Andersson J, Jenkinson M, Antoniades C, Channon KM, Shanmuganathan M, Ferreira VM, Piechnik SK, Klenerman P, Brightling C, Talbot NP, Petousi N, Rahman NM, Ho LP, Saunders K, Geddes JR, Harrison PJ, Pattinson K, Rowland MJ, Angus BJ, Gleeson F, Pavlides M, Koychev I, Miller KL, Mackay C, Jezzard P, Smith SM, Neubauer S. Medium-Term Effects of SARS-CoV-2 Infection on Multiple Vital Organs, Exercise Capacity, Cognition, Quality of Life and Mental Health, Post-Hospital Discharge. E Clinical Medicine. 2021;31:100683.
  5. Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D, Crooks M, Gabbay M, Brady M, Hishmeh L, Attree E, Heightman M, Banerjee R, Banerjee A; COVERSCAN study investigators. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11(3):e048391.
  6. Buonsenso D, Munblit D, De Rose C, Sinatti D, Ricchiuto A, Carfi A, Valentini P. Preliminary evidence on long COVID in children. Acta Paediatr. 2021;110(7):2208-2211. https://doi.org/10.1111/apa.15870
  7. McDonald LT. Healing after COVID- 19: are survivors at risk for pulmonary fibrosis? Am J Physiol Lung Cell Mol Physiol. 2021;320(2):L257-L265. https://doi.org/10.1152/ajplung.00238.2020 
  8. Calabrese F, Pezzuto F, Fortarezza F, Hofman P, Kern I, Panizo A, von der Thesen J, Timofeev S, Gorkiewicz G, Lunardi F. Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists. Virchows Arch. 2020;477(3):359-372.  https://doi.org/10.1007/s00428-020-02886-6
  9. Odilov AA, Cimbalist NS, Volkov AV, Babichenko II. Izmeneniya organov, vyyavlennye pri posmertnom issledovanii pacientov s COVID-19. Arhiv patologii. 2020;82(6):63-69. (In Russ.). https://doi.org/10.17116/patol20208206163
  10. Silva ACS, Silveira KD, Ferreira AJ, Teixeira MM. ACE2, angiotensin-(1-7) and Mas Receptor Axis in Infl ammation and Fibrosis. Br J Pharmacol. 2013;169(3):477-492. 
  11. Tortorici MA, Veesler D. Structural insights into coronavirus entry. Adv Virus Res. 2019;105:93-116. 
  12. Desforges M, Le Coupanec A, Stodola JK, Meessen-Pinard M, Talbot PJ. Human coronaviruses: viral and cellular factors involved in neuroinvasiveness and neuropathogenesis. Virus Res. 2014;194:145-158.  https://doi.org/10.1016/j.virusres.2014.09.011
  13. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Miao X, Li Y, Hu B. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-690. 
  14. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-1069.
  15. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506.  https://doi.org/10.1016/S0140-6736(20)30183-5
  16. Sarzi-Puttini P, Giorgi V, Sirotti S, Marotto D, Ardizzone S, Rizzardini G, Antinori S, Galli M. COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? Clin Exp Rheumatol. 2020;38:337-342. 
  17. Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, Shchendrygina A, Escher F, Vasa-Nicotera M, Zeiher AM, Vehreschild M, Nagel E. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5:1265-1273.
  18. Klok FA, Kruip MJ, Van der Meer NJ, Arbous MS, Gommers DAMPJ, Kant KM, Kaptein FHJ, van Paassen J, Stals MAM, Huisman MV, Endeman H. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thrombosis Res. 2020;191:145-147. 
  19. Samaniego F, Conte G. Infecciyn por SARS-CoV-2. Una nueva enfermedad endotelial trombo-inflamatoria. Rev Med Chil. 2020;148(10):1467-1474. https://doi.org/10.4067/S0034-98872020001001467
  20. Barrantes FJ. The unfolding palette of COVID-19 multisystemic syndrome and its neurological manifestations. Brain Behav Immun Health. 2021;14:100251. https://doi.org/10.1016/j.bbih.2021.100251
  21. Ackermann M, Verleden S, Kueknel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, Li WW, Li VW, Mentzer SJ, Jonigk D. Pulmonary vascular endothlialitis, thombosis, and angiogenesis in Coivd-19. NEJM. 2020;383:120-128. 
  22. Rostami M, Mansouritorghabeh H. D-dimer level in COVID-19 infection: a systematic review. Expert Rev Hematol. 2020;13(11):1265-1275. https://doi.org/10.1080/17474086.2020.1831383
  23. Rowen RJ, Robins H. A plausible «penny» costing effective treatment for corona virus ‒ ozone therapy. J Infect Dis Epidemiol. 2020;6:113.  https://doi.org/10.23937/2474-3658/1510113
  24. Bocci VA. Scientific and medical aspects of ozone therapy. State Art Arch Med Res. 2006;37:425-435.  https://doi.org/10.1016/j.arcmed.2005.08.006
  25. Hernández A, Papadakos PJ, Torres A, González DA, Vives M, Ferrando C, Baeza J. Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19. Dos terapias conocidas podrían ser efectivas como adyuvantes en el paciente crítico infectado por COVID-19. Rev Esp Anestesiol Reanim. 2020;67:245-252.  https://doi.org/10.1016/j.redar.2020.03.004
  26. Murray BK, Ohmine S, Tomer DP, Jensen KJ, Johnson FB, Kirsi JJ, Robison RA, O’Neill KL. Virion disruption by ozone-mediated reactive oxygen species. J Virol Methods. 2008;153:74-77.  https://doi.org/10.1016/j.jviromet.2008.06.004
  27. Kuril’chik AV, Smirnova EV, Bul’da VI. Ozonoterapiya v sovremennoj klinicheskoj praktike. Praktikuyuchij lіkar. 2016;5(3):92-94. (In Russ.).
  28. Litus I. Ozonoterapiya «za» i «protiv». Kosmetolog. 2006;6(20):48-49. (In Russ.).
  29. World Federation of Ozone Therapy website. Website. Accessed July 06, 2020. https://www.wfoot.org/last-news-ozone-and-covid19/
  30. Zheng Z, Dong M, Hu K. A preliminary evaluation on the efficacy of ozone therapy in the treatment of COVID-19. J Med Virol. 2020;92(11):2348-2350. https://doi.org/10.1002/jmv.26040
  31. Alberto Hernández, Montserrat Viñals, Asunción Pablos, Francisco Vilás, Peter J Papadakos, Duminda Wijeysundera, Sergio D. Bergese, Marc Vives Ozone therapy for patients with COVID-19 pneumonia: preliminary report of a prospective case-control study. medRxiv 2020.06.03.20117994; doi: https://doi.org/10.1101/2020.06.03.20117994
  32. Razumov AN, Ponomarenko GN, Badtieva VA. Medicinskaya reabilitaciya pacientov, perenesshih COVID-19 v sanatorno-kurortnyh organizaciyah: Metodicheskie rekomendacii. SPb.; 2021. (In Russ.).
  33. Kotenko KV, Frolkov VK, Nagornev SN, Korchazhkina NB, Gusakova EV, Chelombit’ko EG. Perspektivy primeneniya pit’evyh mineral’nyh vod v reabilitacii pacientov s koronavirusnoj (COVID-19) infekciej: analiz osnovnyh sanogeneticheskih mekhanizmov. Voprosy kurortologii, fizioterapii i lechebnoj fizicheskoj kul’tury. 2021;98(6-2):75-84. (In Russ.). https://doi.org/10.17116/kurort20219806275
  34. Cyganova TN, Frolkov VK, Korchazhkina NB. Patogeneticheskoe obosnovanie primeneniya gipo-giperoksicheskoj trenirovki v lechenii i profilaktike oslozhnenij koronavirusnoj infekcii COVID-19. Fizioterapevt. 2021;1:14-25. (In Russ.). https://doi.org/10.33920/med-14-2102-02

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.